Faculty Information - KATAOKA Hiroshi

（Last updated : 2025-07-03 17:07:20）

KATAOKA Hiroshi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position Assistant Professor

■ Published papers

1.	Original article	Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease. 2025/05/31
2.	Original article	Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report. 2025/03
3.	Original article	Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. 2025/01
4.	Original article	Urinary casts containing crystals in light chain proximal tubulopathy. 2024/11
5.	Original article	Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP) 2024/10
6.	Original article	Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation 2024/08/01
7.	Original article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD 2024/05/31
8.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. 2024/05
9.	Original article	PLA2R-positive membranous nephropathy in IgG4-related disease 2024/02/23
10.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
11.	Original article	Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease 2024/01
12.	Original article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
13.	Original article	Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. 2023/10
14.	Original article	Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal" 2023/07/13
15.	Review article	Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). 2022/11
16.	Original article	Machine learning for morbid glomerular hypertrophy. 2022/11
17.	Original article	Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2022/10/27
18.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. 2022/06
19.	Original article	Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
20.	Original article	Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining. 2022/04
21.	Original article	Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study 2022/03/08
22.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
23.	Original article	Germline Mutations for Kidney Volume in ADPKD 2021/12/13
24.	Original article	Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy:Importance of Type ⅣCollagen 2021/10/12
25.	Original article	Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
26.	Original article	Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
27.	Original article	Renal amyloidosis with monotypic IgM lambda deposition 2021/07
28.	Original article	Renal amyloidosis with monotypic IgM lambda deposition 2021/06/19
29.	Original article	Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease 2021/05
30.	Original article	Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
31.	Original article	The origin of urinary mulberry cells in Fabry 2021/04
32.	Original article	Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
33.	Original article	Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient 2020/12/09
34.	Original article	Cell invasion in glomerular basement membrane: infolding glomerulopathy 2020/12/06
35.	Original article	Sex Differences in Time-Series Changes in Pseudo-R²　Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
36.	Original article	Visceral to subcutaneous fat ratio as an indicator of a ≧30％　eGFR decline in chronic kidney disease 2020/11
37.	Original article	Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan 2020/09/03
38.	Original article	Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2020/08
39.	Original article	A standardized protocol for the mulberry cells and mulberry bodies in the urinary sediment of Fabry disease 2020/07/11
40.	Original article	Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. 2020/05/07
41.	Original article	Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
42.	Original article	High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
43.	Original article	Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
44.	Original article	Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
45.	Original article	Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease. 2019/12/09
46.	Original article	Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
47.	Original article	Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis. 2019/09
48.	Original article	Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
49.	Original article	A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression. 2019/06
50.	Original article	Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
51.	Original article	Low HDL cholesterol as a predictor of chronic kidney disease progression:a cross-classification approach and matched cohort analysis. 2019/03
52.	Original article	PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
53.	Original article	Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
54.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
55.	Original article	Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
56.	Original article	Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
57.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
58.	Original article	Large Renel Corpuscle:Clinical Significance of Evaluation of the Largest Renal Corpuscle in Kidney Biopsy Specimens. 2018/05
59.	Original article	New Insights into Cystic Kidney Diseases. 2018/05
60.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
61.	Original article	Serum Soluble(Pro)Renin Receptor Level is Increased in Association with Impaired Renal Function in Patients with Autosomal Dominant Polycystic Kedney Disease 2018/02
62.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement 2018/01
63.	Original article	Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2017/11
64.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/06
65.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2017/01
66.	Original article	Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis:Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. 2016/10
67.	Original article	Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. 2016/07
68.	Original article	Relationship between variations in time-dependent response to erythropoiesis-stimulating agents and mortality in hemodialysis patients: a single-center study 2016/02
69.	Original article	Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro. 2016
70.	Original article	Relationship between anaemia management at haemodialysis initiation and patient prognosis. 2015/12
71.	Original article	Relationship between anemia management at hemodialysis initiation and patient prognosis. 2015/10
72.	Original article	High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. 2015/08
73.	Original article	Associations between the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index of maintenance hemodialysis patients and increased mortality 2015/01
74.	Original article	Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. 2014/12
75.	Original article	Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients 2012/09
76.	Original article	Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters 2012/02
77.	Original article	Maximal glomeular diameter as a 10-year prognostic indicator for IgA nephropathy 2011
Display 5 items
Display all(77)

■ Academic conference presentation

1.	PLA2R-positive membranous nephropathy in IgG4-related disease （Speech，General） 2025/03/08
2.	Sex Differences and Aging Influence the Association between Kidney Prognosis and Intracranial Aneurysms in Patients with ADPKD: Attribute-Based Medicine (ABM) Insights （Poster notice，General） 2024/10/26
3.	Sex- and Age-Related Variations in Intracranial Aneurysms among Patients with ADPKD: Significance of Middle Cerebral Artery Aneurysms in Elderly Women （Poster notice，General） 2024/10/26
4.	Decreased risk of dialysis-related amyloidosis in the 2010s: Results from Japanese nationwide surveys in 2010 and 2017 （Poster notice，General） 2024/10/25
5.	Diagnostic Utility of Urinary Sediments in Light-Chain Proximal Tubulopathy (LCPT): Report of Three Cases （Poster notice，General） 2024/10/25
6.	Hydroxychloroquine (HCQ)-Associated Zebra and Myeloid Bodies in Patients with Systemic Lupus Erythematosus (SLE) （Poster notice，General） 2024/10/25
7.	Overweight/Obesity and Pulse Pressure: Kidney Prognosis in Young and Elderly Patients with ADPKD Regarding Attribute-Based Medicine (ABM) Insights （Poster notice，General） 2024/10/25
8.	Predialysis Causal Blood Glucose Level and Mortality in Diabetic Patients on Hemodialysis: A Nationwide Cohort Study from Japan （Poster notice，General） 2024/10/25
9.	Sex Differences in Kidney Prognosis in Patients with ADPKD: Attribute-Based Medicine (ABM) Insights （Speech） 2024/10/25
10.	Association of Anemia (Hemoglobin <13 g/dL in Men and <12 g/dL in Women) with Long-Term Kidney Prognosis in Patients with ADPKD: Insights from Time Series Analyses （Poster notice，General） 2024/10/24
11.	Reduced Flippase Activity in the Early Life of Mature Erythrocytes Is Associated with Their Shortened Lifespan in Renal Anemia （Poster notice，General） 2024/10/24
12.	Sex and Aging Influence the Association between Kidney Prognosis and Anemia in Patients with ADPKD: Attribute-Based Medicine (ABM) Insights （Poster notice，General） 2024/10/24
13.	Prevalence and characteristics of intracranial aneurysms and cerebral hemorrhage in patients with autosomal dominant polycystic kidney disease in the Japanese nationwide database （Poster notice，Panelist at Symposium/Workshop (Applied)） 2023/11/04
14.	High hemoglobin and high ESA responsiveness are good prognostic factors in CKD patients: An attribute-based analysis using a cross-classification approach in the BRIGHTEN study （Poster notice，Panelist at Symposium/Workshop (Applied)） 2023/11/02
15.	Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients. （Poster notice，Panelist at Symposium/Workshop (Applied)） 2019/11/07
16.	Clinical and histopathological assessment of hyperuricemia as a predictive marker for progression of nephrosclerosis （Poster notice，General） 2018/02/22
17.	Considering cut off value of waist circumference as a metabolic syndrome component from the point of renal function decline （Poster notice，General） 2018/02/22
18.	Hyperuricemia as a predictor of progression of chronic kidney disease:A matched cohort analysis （Poster notice，General） 2018/02/22
19.	Maximum glomerular/renal corpuscle diameter as a potential prognostic predictor for IgA nephropathy, correlated with obesity/overweight （Poster notice，General） 2018/02/22
20.	Pulse pressure as a predictor of ≥30% eGFR decline or ESRD in patients with CKD. （Poster notice，General） 2018/02/22
21.	Relationship between maximum glomerular/renal corpuscle diameters with serum complement 3 in IgA nephropathy （Poster notice，General） 2018/02/22
22.	Relationship between maximum renal corpuscle diameter with clinical and histopathological pathological factors in IgA nephropathy （Poster notice，General） 2018/02/22
23.	Relationship between pulse pressure and ≥50% eGFR decline or ESRD in CKD patients without diabetes mellitus （Poster notice，General） 2018/02/22
24.	Urine AQP2 Is One of the Candidates for a Surrogate Maker in the Treatment of ADPKD Patients by Tolvaptan （Abstract Only） 2015/11
25.	PROGNOSIS IN IgA NEPHROPATHY: 30-YEAR ANALYSIS OF 1,012 PATIENTS AT A SINGLE CENTER IN JAPAN （Poster notice，General） 2014/05/17
26.	DAMAGE ASSESSMENT IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS IN JAPAN USED BY VASCULITIS DAMAGE INDEX (VDI) （Poster notice，General） 2014/05/16
27.	THE RELATIONSHIP BETWEEN MAXIMAL GLOMERULAR DIAMETER (MAX GD) WITH CLINICAL AND HISTOPATHOLOCICAL FACTORS IN IGA NEPHROPATHY （Poster notice，General） 2014/05/15
28.	Serotonin Antagonist Inhibits Leukocyte-endothelial Interactions In Vivo And In Vitro: Potential contribution Of Pkc-dependent Pathway. （Poster notice，General） 2012/11/05
Display 5 items
Display all(28)

■ Education

1.		Faculty of Medicine, Tokyo Women's Medical University,
2.	1997/04～2003/03	Faculty of Medicine, Kagoshima University, Graduated
3.	1990/04～1994/03	Faculty of Laws, Kyoto University, Graduated